The RECORD Asia-Pacific Atrial Fibrillation Registry

REgistry on Cardiac Rhythm disORDers in Asia-Pacific

The Primary objective of this registry is to assess the control of Atrial Fibrillation (AF) over one year in patients attending clinical or specialized practices.

The Secondary objectives are:

• To describe key demographics and treatment features in AF patients visiting cardiologists in various countries in Asia-Pacific.
• To establish correlation between control of AF and clinical outcomes.
• To establish correlation between treatment strategies and AF control.

Inclusion Criteria:

• Patient presenting with either:

  • History of atrial fibrillation diagnosed < 1 year by standard Electro-Cardiogram (ECG) or by ECG-Holter monitoring (treated or not or whatever rhythm at inclusion).
  • New atrial fibrillation diagnosed by standard ECG or by ECG-Holter monitoring at inclusion visit.

• Patient eligible for a pharmacological treatment of AF (by rhythm or rate control agent).

Exclusion Criteria:

• AF due to transient cause (thyrotoxicosis, alcohol intoxication, acute phase of myocardial infarction, pericarditis, myocarditis, electrocution, pulmonary embolism or other pulmonary disease, hydroelectrolytic disorder, metabolic disorder, etc.).
• Post cardiac surgery AF (≤3 months).
• Mentally disabled patients unable to understand or sign the written informed consent.
• Patients unable to comply with follow-up visits.
• Patients with pacemaker, Implantable Cardioverter Defibrillator (ICD).
• Patients scheduled for pulmonary vein ablation, AV node/His bundle ablation, or pacemaker implantation.
• Patient included in any clinical trial in the previous 3 months.
• Pregnant or breastfeeding women.

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.